Where does Progenity, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Progenity, Inc. ranks #15,553 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Progenity, Inc. hold?

Progenity, Inc. holds 19 US utility patents granted between 2018 and 2022, spanning 14 technology areas.

What is Progenity, Inc.'s Innovation Score?

Progenity, Inc. has an Innovation Score of 40.4 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Progenity, Inc. focus on?

Progenity, Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 8 patents, ranking #2,086 of 7,127 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is Progenity, Inc.'s patent grant rate increasing or decreasing?

Progenity, Inc.'s recent grant velocity is +180% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Progenity, Inc.'s patents?

Progenity, Inc.'s patents average 24.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Progenity, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Progenity, Inc.

USPTO PatentsView assignee record - 19 granted patents across 14 technology areas, recorded in grant years 2018–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Progenity ranks #15,553 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 14 technology areas.

#15,553
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.4/100): 24.4
avg claims per patent: +180%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15553 · US Corporation #15,553 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 19 grants
MID-PACK #15,553/49,997
PHOTO-FINISH Paradigm Sciences
CPC-FOCUS A61B · 14 areas
INNOV-PAR 40.4/100
CLAIMS-DENSE 24.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +180% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Paradigm Sciences Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Progenity’s 40.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.3 pts (26%) Velocity 2.2 pts (5%) Breadth 13.2 pts (33%) Claim depth 14.6 pts (36%)

Qualcomm Incorporated · highest

85
Progenity · this assignee

40
3D Lighting… · lowest

7

What this shows Progenity's Innovation Score is 40.4/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Progenity?

Each dot is one of Progenity’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Progenity’s own 24.4 claims/patent is ABOVE the 17.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Progenity vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Progenity's grants concentrate

Progenity, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 42.1% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2021 (7 grants) versus a trough of 2 in 2019. By volume, Progenity sits between Preferred Technology, LLC and Parallel Systems, Inc..

Progenity's three-year grant acceleration

Progenity, Inc. shows 4 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Preferred Technol…

19
Premark FEG L L C

19
Probiodrug

19
Prodrone

19
Prose

19
Paradigm Sciences

19
Paragon Space Dev…

19
Parallel Systems

19
Progenity ◀

19

What this shows Progenity holds 19 patents at rank #15,535, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Progenity

By rank, the assignees closest to #15,535 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Progenity's primary technology class.

Progenity's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Progenity, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	3	15.8%
2019	2	10.5%
2020	3	15.8%
2021	7	36.8%
2022	4	21.1%

Which technologies does Progenity, Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 8

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

C07K - Peptides 3

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 3

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 3

H04B - Transmission 1

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

G01D - Measuring NOT Specially Adapted FOR A Specific VARIABLE; Arrangements FOR Measuring TWO OR More Variables NOT Covered IN A Single Other SUBCLASS; Tariff Metering APPARATUS; Measuring OR Testing NOT Otherwise Provided FOR 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Progenity, Inc.'s patent record in context - here's where to go next.

Progenity, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 42.1% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #15,553 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Progenity, Inc. against Preferred Technology, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.